No Cover Image

Journal article 1360 views

Adiponectin levels in people with Latent Autoimmune Diabetes-a case control study

S Brophy, H Davies, Jeffrey Stephens Orcid Logo, Sarah Prior Orcid Logo, M Atkinson, Steve Bain, R Williams, Helen Davies, Sinead Brophy Orcid Logo, Mark Atkinson Orcid Logo

BMC Research Notes, Volume: 3, Start page: 317

Swansea University Authors: Jeffrey Stephens Orcid Logo, Sarah Prior Orcid Logo, Helen Davies, Sinead Brophy Orcid Logo, Mark Atkinson Orcid Logo

Full text not available from this repository: check for access using links below.

DOI (Published version): 10.1186/1756-0500-3-317

Abstract

To examine adiponectin levels in people with Latent Autoimmune Diabetes in Adults using a matched pair case control study. Patients with LADA (n = 64), were matched for sex with type 2 diabetic and non-diabetic controls. A matched paired T-test was used to examine average adiponectin levels in the L...

Full description

Published in: BMC Research Notes
Published: 2010
Online Access: http://www.biomedcentral.com/1756-0500/3/317/abstract
URI: https://cronfa.swan.ac.uk/Record/cronfa10727
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract: To examine adiponectin levels in people with Latent Autoimmune Diabetes in Adults using a matched pair case control study. Patients with LADA (n = 64), were matched for sex with type 2 diabetic and non-diabetic controls. A matched paired T-test was used to examine average adiponectin levels in the LADA patients' versus controls. The average adiponectin level for the LADA patients was 9.96 μg/ml compared to 6.4 μg/ml for Type 2 matched controls and 9.6 μg/ml for non-diabetic controls. Mean difference for the LADA-type 2 comparison was calculated after data was log transformed and showed a difference of 1.58 μg/ml (95%CI: 1.28-1.95, p = 0.0001). There was no significant difference between LADA and non-diabetic controls (p = 0.54). Adiponectin levels are higher among people with LADA compared to those with type 2 diabetes and are equivalent to levels seen in non-diabetic controls. This suggests that risk of complications in LADA, as with type 1 diabetes may be related more to glycaemic control rather than to factors of the metabolic syndrome.
College: Faculty of Medicine, Health and Life Sciences
Start Page: 317